Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse eventsIn comparison…
February 04, 2025 07:00 ET | Source: Shattuck Labs, Inc. AUSTIN, TX and DURHAM, NC, Feb. 04, 2025 (GLOBE NEWSWIRE)…
Data presented at Hawaiian Eye and Retina 2025 MeetingResults confirmed that intravitreal ONS-5010 provided early and sustained anatomic improvements, with…
FORT LAUDERDALE, Fla., Jan. 09, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the…
Avid Urges Stockholders to Vote FOR the Pending Transaction TODAY January 08, 2025 17:15 ET | Source: Avid Bioservices, Inc…
MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief…
HONG KONG, Nov. 12, 2024 /PRNewswire/ -- The Shaw Prize presented its awards to five Shaw Laureates today at the…
HONG KONG, Nov. 12, 2024 /PRNewswire/ -- The Shaw Prize presented its awards to five Shaw Laureates today at the…
